替考拉宁

Telavancin

Abstract

No information is available on the use of telavancin during breastfeeding. Telavancin is 93% plasma protein bound and is poorly absorbed orally, so it is not likely to appear in milk in large amounts, reach the infant’s bloodstream or cause any adverse effects in breastfed infants. If telavancin is required by the mother, it is not a reason to discontinue breastfeeding. Monitor the infant for possible effects on the gastrointestinal tract, such as diarrhea, vomiting, and candidiasis (e.g., thrush, diaper rash).

摘要

关于替考拉宁在母乳喂养期间的使用尚无可用信息。替考拉宁与血浆蛋白的结合率为93%，口服吸收差，因此不太可能大量出现在乳汁中、进入婴儿血液或对母乳喂养的婴儿造成任何不良影响。如果母亲需要使用替考拉宁，这不是停止母乳喂养的理由。监测婴儿是否有胃肠道方面的可能影响，如腹泻、呕吐和念珠菌病（如鹅口疮、尿布疹）。